SCHEMBL2984133

SCHEMBL2984133

COc1ccc(NC(=O)C(C)(C)N)nc1NS(=O)(=O)c1ccc(-c2ccc(C)o2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 13/20 0.43
SCN9A Q15858 1/20 0.40
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
PRKDC P78527 1/20 0.37
PIK3C3 Q8NEB9 1/20 0.37
BRD4 O60885 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14398808 0.91 GHSR (0.43) GHSRSCN9ABRD4L3MBTL1HTT
SCHEMBL13267541 0.90 GHSR (0.42) GHSRSCN9ABRD4L3MBTL1HTT
SCHEMBL2984130 0.88 GHSR (0.44) GHSRSCN9AHTT
SCHEMBL4664203 0.84 GHSR (0.44) GHSRHTTNPSR1KDM4EMEN1
SCHEMBL13245951 0.83 ALDH1A1 (0.46) GHSRL3MBTL1NPSR1KDM4EMEN1
SCHEMBL4664054 0.80 KDM4E (0.45) GHSRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL4793678 0.80 GHSR (0.46) GHSRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13245993 0.77 KDM4E (0.48) GHSRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13245995 0.77 GHSR (0.47) GHSRHTTKDM4ELMNAMAPT
SCHEMBL4664206 0.76 ALDH1A1 (0.43) GHSRL3MBTL1NPSR1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US claimed
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR GHSR 1/4885SCN9A 1816/4885PIK3CD 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.